Neuvogen
Blood & Organ Banks · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11095 Flintkote Ave Ste C, San Diego, Ca...Phone Number
(858) 284-0832Website
www.neuvogen.comRevenue
<$5 MillionIndustry
ZI Rank: 7
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
3
7
About Neuvogen
NEUVOGEN is a biotechnology company specializing in immuno-oncology, focusing on the development of therapeutic whole cell cancer vaccines. Their innovative approach aims to transform cancer treatment by addressing the complexity and heterogeneity of solid tumors. NEUVOGEN's whole tumor cell vaccine platform represents a next-generation solution in the fight against cancer. The company targets healthcare providers and patients seeking advanced cancer treatment options.Explore more
Neuvogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuvogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Neuvogen launches new products
Check out if Neuvogen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Neuvogen
Click to see if Neuvogen had a recent Job posting/layoffs
Earning: See what the market has to say on Neuvogen recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Neuvogen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Neuvogen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Neuvogen has new funding data
Recommended Actions
Find VP level buyers at Neuvogen
Find 2 more new buyers
Compare Similar Companies to Neuvogen
Compare insights from companies similar to Neuvogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neuvogen is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Neuvogen is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Neuvogen.
Neuvogen Tech Stack
A closer look at the technologies used by Neuvogen
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in compliance, is in the midst of initiatives related to health and safety. Neuvogen is expected to increase permanent employee workforce to support these efforts. These efforts are focused on increasing the volume of training sessions in this area.
Training, Compliance, Safety, Health & Safety
Project
, according to a mid-level source in compliance, began leveraging AI-driven content creation / generation within the last three months.
Compliance, Artificial Intelligence
Project
, according to a mid-level source in compliance, is in the midst of initiatives related to wellness platforms. Neuvogen is expected to increase permanent employee workforce to support these efforts. These efforts are focused on increasing information sessions.
Compliance, Employee Relations, Enterprise Software, Software, Health & Fitness, HR Operations
Project
, according to a mid-level source in compliance, is planning to leverage AI-driven document drafting over the next three months.
Compliance, Artificial Intelligence
Project
Compliance, Artificial Intelligence, Lead Generation
Neuvogen News & Media
NEUVOGEN Appoints James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D to its Scientific Advisory Board
SAN DIEGO, April 16, 2025 /PRNewswire/ -- NEUVOGEN, Inc., a San Diego based biotechnology company with a next-generation cancer vaccine platform, announced today the appointments of James P. Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., to the company's Scientific Advisory Board (SAB)....NEUVOGEN Appoints Stephen A. Sherwin, M.D. to its Scientific Advisory Board
SAN DIEGO, July 25, 2022 /PRNewswire/ -- NEUVOGEN, an immuno-oncology company with a next-generation cancer vaccine platform, is pleased to announce the appointment of Stephen A. Sherwin, M.D., to the company's Scientific Advisory Board (SAB). "We are extremely honored to have Dr. Sherwin...NEUVOGEN Appoints Vaccine Manufacturing expert, Peter Watler, PhD as Head of Manufacturing Operations
SAN DIEGO, April 11, 2022 /PRNewswire/ -- NEUVOGEN, an immunoncology company, announced today that Peter Watler, PhD has been appointed Head, Manufacturing Operations. He will lead NEUVOGEN's clinical and commercial manufacturing strategy, oversee production of NEUVOGEN's cancer vaccines...NEUVOGEN Appoints Biotechnology Veteran, Mark Backer, PhD as Head of Technical Operations
SAN DIEGO, March 28, 2022 /PRNewswire/ -- NEUVOGEN, an immunoncology company, announced today that Mark Backer, PhD has joined the company as Head of Technical Operations, and will be responsible for leading all aspects of technical operations and chemistry, manufacturing and controls...
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Neuvogen
Sign Up For FreeTo access detailed company insights
NEUVOGEN is a biotechnology company specializing in immuno-oncology, focusing on the development of therapeutic whole cell cancer vaccines. Their innovative approach aims to transform cancer treatment by addressing the complexity and heterogeneity of solid tumors. NEUVOGEN's whole tumor cell vaccine platform represents a next-generation solution in... Read More
